Year: 2023
Type: editorial
Abstract: The US Food and Drug Administration (FDA) has approved two vaccines for prevention of respiratory syncytial virus (RSV) infection in adults ≥60 years old. Both vaccines target the prefusion form of...
Authors: Ronald Ellis, Adam Weiss
Institution: Taylor and Francis (United Kingdom)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,175
OpenAlex ID: W4382602146